Sort   by:  
 Page size 
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, Liver)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-18 | E-GEOD-10140 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, HCC)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-19 | E-GEOD-10141 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Validation Set)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-19 | E-GEOD-10142 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-20 | E-GEOD-10143 | biostudies-arrayexpress
GenomicsSNP6_dataset_control - samples
Control samples using SNP Array 6.0
EGAD00010000504 | EGA
Genomicsena-DATASET-BCCA-07-08-2014-18:03:45:054-88 - samples
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to emergence of treatment-resistant sub-clones. We sought to measure the degree of genomic diversity within primary, untreated HGSC to examine the natural state of tumor evolution prior to therapy. We performe...
EGAD00001000974 | EGA
GenomicsSNP6_dataset_case - samples
Case samples using SNP Array 6.0
EGAD00010000502 | EGA
Genomicsena-DATASET-BCCA-13-08-2014-00:21:04:605-267 - samples
Multi-region whole genome sequencing of an high grade serous ovarian carcinoma sample for characterization of genomic intra-tumoural heterogeneity.
EGAD00001000978 | EGA
GenomicsU133_2_dataset_case - samples
Case samples using U133 Plus 2.0 Array
EGAD00010000500 | EGA
Genomicsena-DATASET-BCCA-26-09-2013-17:41:58:095-167 - samples
High-grade serous ovarian cancer (HGSC) is characterized by poor outcome, often attributed to the emergence of treatment-resistant subclones. We sought to measure the degree of genomic diversity within primary, untreated HGSCs to examine the natural state of tumour evolution prior to therapy. We per...
EGAD00001000669 | EGA
Sort   by:  
 Page size